findmyKOL

Amy Musiek, MD

Basic profile

Washington University in St. Louis

ORCID↗NPI↗
✓ Full record
RegionSaint Louis, MO · MidwestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Amy Musiek is a Dermatology physician affiliated with Washington University in St. Louis. OpenAlex indexes 110 publications with 2,375 citations (h-index 22).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
110publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,375citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4901 Forest Park Ave
Div Im Dermatology, Ste 502
Saint Louis, MO 631081495

Telephone

314-273-3376

Registry record last updated 17 Apr 2025.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    25.4%
    Corticosteroid19.4%
    Triamcinolone Acetonide57%Triamcinolone acetonide43%
    Part D + Part B≥114 patients
    Interleukin-4 Receptor alpha Antagonist4.7%
    Dupixent Pen64%Dupixent Syringe36%
    Part D<11 patients

    + 2 more classes in this area

  • Anti-infectives

    23.4%
    Azole Antifungal7.8%
    Ketoconazole100%
    Part D≥64 patients
    Lincosamide Antibacterial5%
    Clindamycin Phosphate100%
    Part D≥30 patients

    + 5 more classes in this area

  • Sensory organs

    17.2%
    Corticosteroid16.2%
    Clobetasol Propionate60%Hydrocortisone33%Betamethasone Dipropionate7%
    Part D≥90 patients
    Aminoglycoside Antibacterial1%
    Gentamicin Sulfate100%
    Part D<11 patients
Where care is delivered (Part B)6.7% facility · 93.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”